SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
批准号:
3860922
负责人:
D S GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
adrenal medulla angiotensin /renin /aldosterone hypertension catecholamines dihydroxyphenylalanine dopamine epinephrine homeostasis human subject human tissue laboratory rat microdialysis neurochemistry neurotransmitter biosynthesis norepinephrine physiologic stressor positron emission tomography radiotracer stress sympathetic nervous system yohimbine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Catecholamines are important in normal physiology, stress, and disease.
The adrenomedullary hormonal and sympathetic neural components of the
sympathoadrenal system use the catecholamines, epinephrine (EPI) and
norepinephrine (NE) as the main effector biochemicals. The
catecholamines dopamine (DA) and NE are important central
neurotransmitters. In the kidney, DA participates in sodium balance.
Our goals have been to: (1) understand how the sympathoadrenal system is
regulated and its function coordinated with that of other systems; (2)
determine the role of brain NE in the expression of neuroendocrine stress
responses; and (3) identify bases for abnormal renal Dopa-DA function in
disorders of sodium homeostasis such as salt-sensitive hypertension.
Positron emission tomography (PET) scanning after systemic administration
of [18F]-6-fluorodopamine ([18F]-6F-DA) provided the first noninvasive,
in vivo means to examine cardiac sympathetic innervation and function in
humans. A multielectrode array electrochemical detector (neurochemical
analyzer) was used to assay plasma and urine levels of [18F]-6-DA in
humans, and the neurochemical results indicated that [18F]-6-DA is taken
up into sympathetic nerve endings and converted to the fluorinated analog
of NE. Combined direct sympathetic nerve recording and measurement of
regional NE spillover was used to demonstrate that systemic
administration of the alpha2-adrenoceptor antagonist, yohimbine,
increases NE release by both stimulating sympathoneural outflow and
blocking presynaptic alpha2-receptors in humans. in a distinct subgroup
of patients with essential hypertension, sympathoadrenal hyperreactivity
was indicated by yohimbine challenge testing. In vivo microdialysis in
rats showed that yohimbine releases NE into the arterial plasma and into
brain extracellular fluid, and that hypercortisolemia abolishes
yohimbine-induced release of NE in the brain and periphery. Further
evidence for a relationship between endogenous plasma Dopa and
catecholamine biosynthesis was obtained in rats, and abnormally increased
urinary excretion of Dopa and a low urinary DA: Dopa ratio were found in
patients with saltsensitive hypertension. PET scanning, neurochemical
analysis, microdialysis, direct sympathetic nerve recording, and
molecular biological techniques will be used to elucidate the roles of
catecholaminergic systems in health, stress, and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7901216
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2009
-
负责人:D S GOLDSTEIN
-
依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
-
批准号:4694553
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
-
批准号:3966593
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINE FUNCTION IN HEALTH
-
批准号:6163057
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8380488
-
项目类别:
-
资助金额:$7.55万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
-
批准号:5203972
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
-
批准号:3846315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
-
批准号:3782423
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
-
批准号:4694562
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
-
批准号:3966596
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8538521
-
项目类别:
-
资助金额:$7.83万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8150400
-
项目类别:
-
资助金额:$8.71万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
-
批准号:3760325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL FUNCTION IN HEALTH AND DISEASE
-
批准号:3879001
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
CLINICAL PHYSIOLOGY OF HYPERTENSION
-
批准号:4694561
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
COLLABORATIVE STUDIES OF NEUROENDOCRINE CIRCULATORY CONTROL
-
批准号:4694554
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
SYMPATHOADRENAL AND CATECHOLAMINE FUNCTION IN HEALTH
-
批准号:6111886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
CLINICAL PHYSIOLOGY OF HYPERTENSION
-
批准号:3966595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
-
批准号:3966592
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位:
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8327848
-
项目类别:
-
资助金额:$7.88万
-
财政年份:--
-
负责人:D S GOLDSTEIN
-
依托单位: